Anticorps Recombinant de lapin anti-Phospho-SMAD9 (Ser465/467)

Phospho-SMAD9 (Ser465/467) Recombinant Antibody for WB, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, ELISA

Conjugaison

Non conjugué

CloneNo.

240470A12

N° de cat : 80144-2-PBS

Synonymes

SMAD9, SMAD 9, Mothers against DPP homolog 9, MADH9, MADH6



Informations sur le produit

80144-2-PBS cible Phospho-SMAD9 (Ser465/467) dans les applications de WB, ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Peptide
Nom complet SMAD family member 9
Masse moléculaire calculée 430 aa, 49 kDa
Poids moléculaire observé 55 kDa
Numéro d’acquisition GenBankBC011559
Symbole du gène SMAD9
Identification du gène (NCBI) 4093
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Mothers against decapentaplegic homolog 9 also known as SMAD9, SMAD8, and MADH6, belongs to the SMAD family of proteins, which belong to the TGFβ superfamily of modulators. Like many other TGFβ family members, SMAD9 is involved in cell signalling. When a bone morphogenetic protein binds to a receptor (BMP type 1 receptor kinase) it causes SMAD9 to interact with SMAD anchor for receptor activation (SARA).The binding of ligands causes the phosphorylation of the SMAD9 protein and the dissociation from SARA and the association with SMAD4. It is subsequently transferred to the nucleus where it forms complexes with other proteins and acts as a transcription factor. SMAD9 is a receptor regulated SMAD (R-SMAD) and is activated by bone morphogenetic protein type 1 receptor kinase. There are two isoforms of the protein. The antibody recognizes both SMAD1 and SMAD5 protein phosphorylated at Ser463/465.

{{ptg:RelatedPrimaryAntibodies}}